Edaravone and mitochondrial transfer as potential therapeutics for vanishing white matter disease astrocyte dysfunction

INTRODUCTION: Previous research has suggested that vanishing white matter disease (VWMD) astrocytes fail to fully differentiate and respond differently to cellular stresses compared to healthy astrocytes. However, few studies have investigated potential VWMD therapeutics in monoculture patient‐deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Neville S., Newbery, Michelle, Touffu, Aude, Maksour, Simon, Chung, Johnson, Carroll, Luke, Zaw, Thiri, Wu, Yunqi, Ooi, Lezanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401142/
https://www.ncbi.nlm.nih.gov/pubmed/36971196
http://dx.doi.org/10.1111/cns.14190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401142/
https://www.ncbi.nlm.nih.gov/pubmed/36971196
http://dx.doi.org/10.1111/cns.14190

Ejemplares similares